Name

CP-Pharma

Legal name

CP-Pharma Handelsgesellschaft mbH

Website

https://cp-pharma.de

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

Veterinary Pharmaceutical Wholesalers & Distributors (HLAMAIAA)

akta.pro secondary industries

Generic & Private-Label Veterinary Pharmaceuticals (HLAMAEAM), Pet Pharmaceuticals & Veterinary Supply Distribution (CRAOAKAD)

Keywords

• Veterinary pharmaceuticals
• Animal prescription medicines
• Veterinary drug distribution
• Pharmaceutical wholesale
• Veterinary continuing education

Headquarters

HQ city

Burgdorf

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Veterinary Pharmaceutical Distribution: CP-Pharma operates as a wholesale distributor of veterinary pharmaceuticals, selling prescription animal medicines exclusively to licensed veterinarians, animal clinics, and universities through their protected online shop and direct sales force. The company holds over 180 self-approved product registrations in Germany.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

CP-Pharma Handelsgesellschaft mbH is a German veterinary pharmaceutical wholesale distributor that sells prescription animal medicines exclusively to licensed veterinarians, animal clinics, and universities in Germany. The company holds over 180 self-approved product registrations covering nearly all therapeutic areas of veterinary medicine (antibiotics, anti-inflammatory drugs, anesthetics, antiparasitics, ophthalmic preparations, dermatological products, cardiovascular, gastrointestinal, metabolic/vitamin supplements, homeopathic products, and specialty items such as euthanasia solutions). Distribution is conducted through a protected online shop requiring customer authentication and a direct field sales force conducting approximately 25,000 customer visits per year.

Product overview

CP-Pharma Handelsgesellschaft mbH is a German veterinary pharmaceutical company founded in 1977, operating as a B2B supplier exclusively for veterinarians, animal clinics, and universities. The company offers an extensive portfolio of over 180 self-approved veterinary pharmaceutical products in Germany, covering nearly all areas of veterinary medicines including antibiotics (Amoxicillin, Marbosol, Genta), anti-inflammatory/pain medications (Meloxicam/Loxitab, Carprofen/Carprotab, Ketoprofen/Ketoprosol), anesthetics (Ketamin, Isofluran, Propofol), parasiticides (Fenbenol, Levamisol), ophthalmic preparations (Dexavet, Hyalopanthen), and supplements. The company also offers combination product bundles (Kombis) organized by therapeutic area (Equi Kombi, Augen Kombi, Magen-Darm Kombi, etc.), as well as educational services through the CPlus training program. Products are sold exclusively through their protected online shop requiring customer authentication, with approximately 25,000 annual customer visits and a 94% repeat customer rate.

Differentiator

Problem solved

Functional benefit

Brands

• CPlus: CP-Pharma's own continuing education (Fortbildung) brand offering training for veterinary practitioners, including webinars and in-person seminars
• CPlus Kombis

Products and services

• Veterinary Antibiotics (Antibiotika) Broad portfolio of antibiotic products for veterinary use including Amoxicillin products (Amox, Amoxitab, Amoxicillin-Uterusstäbe), Marbosol (marbofloxacin injection), Genta (gentamicin injection), Cefatab vet. (cefalexin flavoured tablets 50/250/500/1000 mg), Doxytab vet. (doxycycline flavoured tablets), Enrotab (enrofloxacin tablets), Amoxiclav (amoxicillin/clavulanic acid combination), Cefalexin tablets, and Bigram (combination anti-inflammatory and antibiotic injection for livestock). Sold exclusively to licensed veterinarians.
• Anti-inflammatory and Analgesic Medications (Antiphlogistika) Anti-inflammatory, analgesic and pain management products for dogs, cats, horses, and livestock, including Meloxicam (Loxitab 1 mg / 2.5 mg tablets, Melosolute injection 5 mg/ml and 20 mg/ml, Melosus 0.5 mg/ml for cats and guinea pigs), Carprofen (Carprotab tablets and Carprosol injection, including flavoured options), Phenylbutazon Injektionslösung (returned to the portfolio in February 2026), Ketoprosol (ketoprofen injection), Novacen N (analgesic/anti-inflammatory injection), Flunidol RPS (anti-inflammatory injection for cattle, horses, pigs), Butorgesic (butorphanol analgesic injection), and Bupresol vet. (buprenorphine analgesic multidose injection). Sold exclusively to licensed veterinarians.
• Anesthetic Products (Anästhetika) Injectable and inhalation anesthetic products for veterinary surgical and procedural use, including Ketamin injection solution (10 ml, 25 ml, and 50 ml volumes), Isofluran CP inhalation anesthetic in 250 ml bottles, Cepetor KH (medetomidine injectable sedative), Narkodorm (anesthetic injection solution), and Vet-Gel lubricating gel for veterinary procedures (500 ml and 1000 ml). Sold exclusively to licensed veterinarians.
• Antiparasitic and Repellent Products (Antiparasitika / Repellentien) Antiparasitic and ectoparasiticide products for veterinary use, including Fenbenol (fenbendazole deworming injector for livestock), Levamisol (antiparasitic injection solution), Cepellent Spray (ectoparasiticide spray for animal health), and Fugasol (oral solution in 25 ml, 50 ml, and 100 ml volumes). Sold exclusively to licensed veterinarians.
• Respiratory Medications (Atemwege) Respiratory medications for animals, including Hexasolvon (bromhexine-based injection solution and oral powder) and Analeptol (respiratory stimulant injection solution). Sold exclusively to licensed veterinarians.
• Ophthalmic Preparations (Augenpräparate) Eye care preparations for dogs and cats, including Dexavet (dexamethasone-based eye drops and eye ointment), Hyalopanthen (hyaluronic acid and dexpanthenol eye drops), and Vitamycin (eye ointment). Sold exclusively to licensed veterinarians.
• Endocrine and Glucocorticoid Products (Endokrinologie / Glukokortikoide) Endocrine and glucocorticoid products for veterinary use, notably Thyrasol thyroid medication for animals featuring a new mg-scaling dosing syringe for improved dosage accuracy. Sold exclusively to licensed veterinarians.
• Dermatological Products (Haut / Haare) Skin, coat and wound care products for veterinary use, including Iodovet-Spray (iodine-based antiseptic spray), Nekrolyt Salbe (ointment for wound and skin treatment), Mielosan (medical honey-based wound care products in ointment, spray, and ear drops formulations), Herbax (skin care ointment 70 g), Zinkoxyd-Salbenspray (zinc oxide-based salve spray), and EFA-Omega (essential fatty acid supplement for dogs and cats in 250 ml). Sold exclusively to licensed veterinarians.
• Cardiovascular Products (Herz / Kreislauf) Cardiac and diuretic medications for veterinary use, including Catophos (cardiac medication injection solution), Diuren (diuretic injection solution), and Furotab (furosemide-based diuretic tablets for dogs and cats in 10 mg and 40 mg strengths). Sold exclusively to licensed veterinarians.
• Gastrointestinal Medications (Magen / Darm)
• Metabolic and Vitamin Supplements (Stoffwechselprodukte / Vitamine)
• Homeopathic Veterinary Products (Homöopathika)
• Specialty Veterinary Products (Spezialitäten) Specialty veterinary products including Euthadorm (pentobarbital-based injectable euthanasia solution) and other specialized formulations outside the standard therapeutic groups. Sold exclusively to licensed veterinarians.
• Combination Product Bundles (Kombis) Convenience product bundles combining multiple related veterinary products organized by therapeutic area, including Antibiotika Kombi, Augen Kombi (eye combo, including Dexavet), Epilepsie Kombi, Equi Kombi (horse combo, including Buscosol), Haut Kombi, Herz Kombi, Hormon Kombi, Magen-Darm Kombi (gastrointestinal combo, including Buscosol), NASA Kombi, and Relaxan Kombi. Designed for convenience procurement by veterinary practices.
• CPlus Continuing Education Program (CPlus Fortbildungen) CP-Pharma's own continuing education brand offering professional training for veterinary practitioners, including CPlus Kleintier (small animal) webinars and DHP (Der Herausfordernde Patient) webinar series. Topics include symptom-based diagnosis (vomiting), MCP for exotic pets, puppy diseases, and Cushing's disease in dogs. Live webinars and in-person sessions qualify for ATF (Continuing Education) hours. Over more than 10 years, approximately 15,000 practitioners have participated. Sessions are organized in partnership with VETWORKING.
• Arnstädter Anesthesia Seminars (Arnstädter Narkoseseminare) One-day inhalation anesthesia training seminars supported by CP-Pharma in cooperation with Tiergesundheitszentrum Arnstadt, covering practical demonstrations and theoretical knowledge of inhalation anesthesia for veterinarians. Sessions are held in Dortmund, Hannover, Frankfurt, Berlin, Köln, and Arnstadt and qualify for 7 ATF hours each.

Quantifiable outcome

• 94% of customers are regular/repeat customers
• +1 more outcomes

Named customers3 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• VETWORKING (Veranstaltungsbüro)coreImplementation/ SI/ Consulting PartnerVETWORKING serves as the event organizer for CP-Pharma's CPlus continuing education program, managing registration and logistics through their cplus.vetworking.de platform. This partnership enables CP-Pharma to deliver professional training to veterinary practitioners.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Vetoquinol: France-based independent veterinary pharmaceutical company with a broad, primarily generic-leaning portfolio of companion and livestock medicines distributed across Europe. Highly comparable to CP-Pharma in scale and go-to-market model (B2B via vet channel with strong field sales).
• Virbac: Independent French veterinary pharmaceutical company focused exclusively on animal health across companion animals, livestock, and aquaculture. Closely comparable independent specialist competitor with similar mixed branded/generic positioning and global distribution.
• Ceva Santé Animale: Independent French veterinary pharma player spanning companion-animal, livestock, and vaccines. Comparable as another big-independent specialist operating in therapeutics outside the diagnostics/top-3 incumbents, with a similar broad-portfolio strategy.
• Dechra Pharmaceuticals (now part of Zoetis): UK-origin veterinary pharma specialist (acquired by Zoetis 2025) focused on companion-animal therapeutics and specialty generics. Closely matched to CP-Pharma's therapeutic-area depth and European footprint.
• WDT (Wirtschaftsgenossenschaft Deutscher Tierärzte): Germany's veterinarian-owned veterinary distribution cooperative; the dominant specialist B2B distributor to German veterinary practices. Direct peer competing head-to-head with CP-Pharma for veterinary clinic and practice accounts in Germany.
• AniMedica (now part of the Dechra/Zoetis group): German veterinary pharmaceutical specialist with a comparable product portfolio (anti-infectives, anti-inflammatories, anesthetics) primarily serving German veterinarians. Most direct German-in-market comparable to CP-Pharma before its recent ownership change.

Broad incumbents

• Zoetis (formerly Pfizer Animal Health): World's largest animal-health company with a comprehensive portfolio across therapeutics, vaccines, diagnostics, and parasiticides. Represents the dominant broad incumbent CP-Pharma competes against for veterinary practice share in Germany.
• MSD Tiergesundheit / MSD Animal Health (Intervet): Global animal-health division of Merck & Co., a top-3 incumbent with deep German presence (Intervet legacy). Direct competitor in pharma distribution to German veterinary practices.
• Boehringer Ingelheim Animal Health: Global animal-health division of Boehringer Ingelheim with significant German footprint across vaccines, parasiticides, and therapeutics. Comparable as a key broad incumbent CP-Pharma faces in the German veterinary channel.
• Elanco Animal Health: Major global animal-health incumbent (post-Bayer Animal Health acquisition) with companion-animal and livestock therapeutics. Represents another broad incumbent competing for German veterinary practice wallet share.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cp-pharma-handelsgesellschaft-mbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CP-Pharma